Gastrointestinal Tumors
21
8
10
4
Key Insights
Highlights
Success Rate
67% trial completion
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 62/100
9.5%
2 terminated out of 21 trials
66.7%
-19.8% vs benchmark
10%
2 trials in Phase 3/4
25%
1 of 4 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 4 completed trials
Clinical Trials (21)
A Study of SKB571 in Participants With Gastrointestinal Tumors
KQB198 in Combination With Imatinib in Participants With Advanced/Metastatic GIST in 1st Line Setting
Non-Dressing vs. Routine Dressing Change After Gastrointestinal Cancer Surgery
A Study of BL-M24D1 in Patients With Locally Advanced or Metastatic Gastrointestinal Tumors and Other Solid Tumors
A Study of E7386 in Participants With Advanced Solid Tumor Including Colorectal Cancer (CRC)
A Study of Lutetium [177Lu] BL-ARC001 in Patients With Locally Advanced or Metastatic Gastrointestinal Tumors and Other Solid Tumors
A Study of SYS6010 in Combination With SYH2051 in Patients With Advanced Colorectal Cancer and Other Gastrointestinal Tumors
Phase 1 Trial of AZD6422 in CLDN18.2+ GI Tumors
Personalized mRNA Cancer Vaccine for Gastrointestinal Solid Tumor Treatment
Combined Screening for Gastrointestinal Tumors
Study to Test the Safety and Tolerability of PF-07062119 in Patients With Selected Advanced or Metastatic Gastrointestinal Tumors.
The Use of Propranolol in the Perioperative Period of Resectable Gastrointestinal Tumors
A Study of GNC-077 in Patients With Locally Advanced or Metastatic Gastrointestinal Tumors and Other Solid Tumors
PD-L1 Targeting Molecular Imaging of Solid Tumors
BGT007H Cells for the Treatment of Recurrent/Refractory Gastrointestinal Tumors
Anlotinib Plus Chemotherapy as First-line Therapy for Gastrointestinal Tumor Patients With Unresectable Liver Metastasis (ALTER-G-001)
Effects of Immunonutrition on the Improvement of Postoperative Adjuvant Chemotherapy Related Adverse Reactions in Patients With Gastrointestinal Tumors
Phase II Study of Reuse of Oxaliplatin Hypersensitivity in Gastrointestinal Tumors
Study of Everolimus Treatment in Newly-diagnosed Patients With Advanced Gastrointestinal Neuroendocrine Tumors
The Impact of Preoperative Oral Glutamine Intake on the Immunocompetence and Outcomes of Malnourished Patients Undergoing Major Abdominal Surgery Due to Malignancies